Proxy Statement Reveals Delinquent Insider Reports and Details Auditor Changes Amidst Financial Restatements
SNWV is trading near its 52-week low of $16.27 (2.1% above the low) on elevated volume (2.4× avg).
Summary
SANUWAVE Health's definitive proxy statement reveals compliance failures with delinquent insider reports and details a history of auditor changes and material weaknesses in financial controls.
Key Events · Corporate Governance and Compliance · SNWV
-
Delinquent Insider Reports
Multiple directors (Morgan Frank, Gregory Bazar, Jeffrey Blizard, Ian Miller, James Tyler) and a 5%+ owner (Opaleye Management Inc.) failed to timely file Section 16(a) reports for 2025, indicating compliance lapses.
-
Auditor Changes and Concerns
The filing details a history of recent auditor changes (Marcum to CBIZ CPAs to Baker Tilly US, LLP) and notes that prior auditors identified "going concern" issues and "material weaknesses" in internal controls.
-
Clawback Policy Disclosure
The company approved a clawback policy in March 2025 and conducted a recovery analysis following prior financial restatements, but determined no recovery was required for the relevant period as no incentive-based compensation was received.
-
Annual Meeting Proposals
Shareholders will vote on June 11, 2026, on the election of five directors, ratification of Baker Tilly US, LLP as the independent auditor, and an advisory vote on executive compensation.
Analysis · SNWV · Industrial Applications And Services
This definitive proxy statement, while a routine annual filing, highlights significant corporate governance and financial reporting issues. It discloses that multiple directors and a major shareholder failed to timely file Section 16(a) reports for 2025, indicating a lapse in compliance. Furthermore, the filing provides a detailed history of recent auditor changes, noting that previous auditors (Marcum) included a "going concern" paragraph and both Marcum and CBIZ CPAs identified "material weaknesses" in internal controls. Although a clawback policy was approved and a recovery analysis conducted following prior financial restatements, no incentive-based compensation recovery was required for the relevant period. These disclosures, especially with the stock trading near 52-week lows, underscore ongoing challenges in financial oversight and compliance.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.6% of the 1645 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SNWV was trading at $16.61 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $142.7M. The 52-week trading range was $16.27 to $46.59. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.